TY - JOUR
T1 - The ribonucleotide reductase subunit M2B subcellular localization and functional importance for DNA replication in physiological growth of KB cells
AU - Liu, Xiyong
AU - Zhou, Bingsen
AU - Xue, Lijun
AU - Shih, Jennifer
AU - Tye, Karen
AU - Qi, Christina
AU - Yen, Yun
N1 - Funding Information:
This was a NIH Grant (CA 72767) supported project. I would like to acknowledge Lucy Brown and Spalla Claudio for helping to run the flow cytometry, as well as Mariko Lee for conducting confocal microscopy in co-facility laboratories at City of Hope. I appreciate Kristine Justus’ efforts in editing and critiquing this paper.
PY - 2005/11/1
Y1 - 2005/11/1
N2 - Ribonucleoside diphosphate reductase (EC 1.17.4.1) (RR) is a potential target for antineoplastic agents due to its crucial role in DNA replication and repair. The expression and activity of RR subunits are highly regulated to maintain an optimal dNTP pool, which is required to maintain genetic fidelity. The human RR small subunit M2B (p53R2) is thought to contribute to DNA repair in response to DNA damage. However, it is not clear whether M2B is involved in providing dNTPs for DNA replication under physiological growth conditions. Serum starvation synchronized studies showed that a rapid increase of M2B was associated with cyclin E, which is responsible for regulation of G 1/S-phase transition. A living cell sorting study that used KB cells in normal growth, further confirmed that M2B increased to maximum levels at the G1/S-phase transition, and decreased with DNA synthesis. Confocal studies revealed that M2B redistributed from the cytoplasm to the nucleus earlier than hRRM2 in response to DNA replication. Nuclear accumulation of M2B is associated with dynamic changes in dNTP at early periods of serum addition. By using M2B-shRNA expression vectors, inhibition of M2B may result in growth retardation in KB cells. We conclude that M2B may translocate from the cytoplasm into the nucleus and allow dNTPs to initiate DNA synthesis in KB cells under physiological conditions. Thus, our findings suggested that M2B might play an important role for initiating DNA replication of KB cells in normal growth.
AB - Ribonucleoside diphosphate reductase (EC 1.17.4.1) (RR) is a potential target for antineoplastic agents due to its crucial role in DNA replication and repair. The expression and activity of RR subunits are highly regulated to maintain an optimal dNTP pool, which is required to maintain genetic fidelity. The human RR small subunit M2B (p53R2) is thought to contribute to DNA repair in response to DNA damage. However, it is not clear whether M2B is involved in providing dNTPs for DNA replication under physiological growth conditions. Serum starvation synchronized studies showed that a rapid increase of M2B was associated with cyclin E, which is responsible for regulation of G 1/S-phase transition. A living cell sorting study that used KB cells in normal growth, further confirmed that M2B increased to maximum levels at the G1/S-phase transition, and decreased with DNA synthesis. Confocal studies revealed that M2B redistributed from the cytoplasm to the nucleus earlier than hRRM2 in response to DNA replication. Nuclear accumulation of M2B is associated with dynamic changes in dNTP at early periods of serum addition. By using M2B-shRNA expression vectors, inhibition of M2B may result in growth retardation in KB cells. We conclude that M2B may translocate from the cytoplasm into the nucleus and allow dNTPs to initiate DNA synthesis in KB cells under physiological conditions. Thus, our findings suggested that M2B might play an important role for initiating DNA replication of KB cells in normal growth.
KW - Cell cycle
KW - Cell proliferation
KW - DNA replication
KW - Ribonucleotide reductase
KW - Small interference RNA
KW - Subcellular localization
UR - http://www.scopus.com/inward/record.url?scp=25644455941&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=25644455941&partnerID=8YFLogxK
U2 - 10.1016/j.bcp.2005.08.005
DO - 10.1016/j.bcp.2005.08.005
M3 - Article
C2 - 16168962
AN - SCOPUS:25644455941
SN - 0006-2952
VL - 70
SP - 1288
EP - 1297
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 9
ER -